Acute Myeloid Leukemia

Acute Myeloid Leukemia (AML) is a malignancy of the myeloid line of blood cells, characterized by the rapid growth of abnormal cells that build up in the bone marrow and blood, interfering with normal blood cell production.

AML arises from somatic mutations in hematopoietic stem cells. While most cases are sporadic, genetic predispositions (e.g., Down syndrome), exposure to ionizing radiation, chemotherapy (t-AML), and benzene exposure are documented triggers.

The disease involves the clonal expansion of undifferentiated myeloid blasts that fail to undergo terminal differentiation. This results in bone marrow failure, causing anemia, neutropenia, and thrombocytopenia.

Median age at diagnosis is 68 years. It accounts for approximately 1% of all cancer deaths. Males are slightly more affected than females.

• Prior chemotherapy or radiation therapy
• Exposure to benzene/pesticides
• Smoking
• Genetic disorders (Fanconi anemia, Bloom syndrome)
• Myelodysplastic syndromes (MDS)

A. Early Symptoms: Fatigue, unexplained weight loss, night sweats.
B. Common Symptoms: Pallor, bruising, petechiae, epistaxis.
C. Advanced Symptoms: Bone pain, hepatosplenomegaly, lymphadenopathy.
D. Emergency Symptoms: Hyperleukocytosis causing respiratory distress or CNS confusion (leukostasis), febrile neutropenia, disseminated intravascular coagulation (DIC).

Pallor (anemia), tachycardia, ecchymosis/petechiae (thrombocytopenia), gum hypertrophy (specifically in M4/M5 subtypes), and splenomegaly.

A. Clinical Assessment: Symptom history and physical exam.
B. Laboratory Testing: CBC with differential, peripheral blood smear.
C. Imaging Studies: Chest X-ray to rule out mediastinal mass.
D. Functional Tests: Cardiac ECHO (baseline for anthracyclines).
E. Biopsy Findings: Bone marrow aspirate showing >20% blasts.
F. Genetic Testing: Cytogenetics (karyotyping) and NGS for mutations (FLT3, NPM1, IDH1/2).
G. Differential Diagnosis: ALL, CML in blast crisis, myelodysplastic syndromes.

Complete Blood Count (CBC)
Type: Blood Test
Purpose: Identify cytopenias or leukocytosis.
Expected Findings: Anemia, thrombocytopenia, abnormal WBC.
Interpretation: Suggestive of marrow failure.

Chest X-ray: Used to evaluate for leukemic infiltrates or associated infections.
CT Scan: Used if extramedullary disease is suspected.

Acute Lymphoblastic Leukemia (ALL) (differentiated by immunophenotyping); Aplastic anemia (lacks blasts).

Infection, bleeding, tumor lysis syndrome, and venous thromboembolism.

A. Lifestyle Modifications: Avoid infection risks, neutropenic diet.
B. Preventive Measures: Vaccination against influenza/pneumonia.
C. Medical Treatment:

• Induction: Cytarabine + Anthracycline (7+3 regimen).


• Targeted: Midostaurin (FLT3 inhibitors), Venetoclax.

Prognosis is highly variable, depending on cytogenetic risk factors. 5-year survival is approximately 30-40% in younger adults but significantly lower in older patients.

Avoidance of chemical toxins (benzene) and limited exposure to diagnostic radiation.

The following homeopathic remedies have been historically indicated for symptoms associated with Acute Myeloid Leukemia. Selection should be based on individualized symptom totality and constitutional assessment.

• Homeopathy by Hadhrat Mirza Tahir Ahmad (r.a.) — Primary clinical reference
• Robin Murphy — Lotus Materia Medica (3rd Edition)
• William Boericke — Pocket Manual of Homœopathic Materia Medica & Repertory
• ICD-10/ICD-11 Classification — World Health Organization
• Harrison's Principles of Internal Medicine (Reference Standard)

This clinical reference profile is compiled from authoritative medical sources for educational purposes. Always verify clinical data with current medical guidelines.

🔬 Lab Report Analyzer (Diagnostic Verification)

Upload your laboratory bloodwork PDF or paste your report text to automatically extract markers, detect units, and identify reference range variances related to Acute Myeloid Leukemia.